Best TWAS P=1.34e-08 · Best GWAS P=1.65e-07 conditioned to 0.00827
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | RHCE | 0.29 | 0.34 | lasso | 4 | 0.34 | 2.0e-42 | -5.2 | 5.2 | 1.8e-07 | -0.98 | 0.01 | 0.99 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | TMEM50A | 0.32 | 0.37 | lasso | 8 | 0.37 | 6.9e-47 | -5.2 | 5.2 | 1.9e-07 | -0.98 | 0.02 | 0.98 | FALSE |
3 | GTEx | Artery Aorta | TMEM57 | 0.14 | 0.15 | enet | 10 | 0.14 | 3.3e-08 | -5.0 | 5.2 | 1.7e-07 | -0.94 | 0.02 | 0.98 | FALSE |
4 | GTEx | Breast Mammary Tissue | RP11-335G20.7 | 0.23 | 0.10 | enet | 5 | 0.09 | 2.4e-05 | -5.2 | -5.2 | 1.7e-07 | 0.97 | 0.02 | 0.98 | FALSE |
5 | GTEx | Breast Mammary Tissue (Male) | MTFR1L | 0.11 | 0.00 | enet | 18 | -0.01 | 4.6e-01 | 1.5 | 5.7 | 1.3e-08 | -0.53 | 0.04 | 0.30 | TRUE |
6 | GTEx | Cells Transformed fibroblasts | C1orf63 | 0.09 | 0.04 | lasso | 5 | 0.03 | 2.5e-03 | -5.1 | -5.2 | 2.3e-07 | 0.95 | 0.02 | 0.97 | FALSE |
7 | GTEx | Testis | TMEM57 | 0.25 | 0.11 | enet | 17 | 0.12 | 7.4e-06 | -5.1 | 5.5 | 4.0e-08 | -0.85 | 0.02 | 0.98 | FALSE |
8 | GTEx | Thyroid | TMEM50A | 0.19 | 0.11 | lasso | 2 | 0.08 | 2.0e-06 | -5.2 | -5.2 | 2.2e-07 | 0.99 | 0.01 | 0.98 | FALSE |
9 | GTEx | Uterus | TMEM50A | 0.29 | 0.11 | enet | 15 | 0.04 | 6.0e-02 | -2.9 | -5.1 | 2.9e-07 | 0.71 | 0.03 | 0.65 | FALSE |
10 | GTEx | Whole Blood | TMEM50A | 0.08 | 0.07 | lasso | 2 | 0.07 | 4.7e-07 | -5.2 | -5.2 | 2.5e-07 | 0.99 | 0.01 | 0.98 | FALSE |
11 | ROSMAP | Brain Pre-frontal Cortex | RHCE | 0.29 | 0.36 | lasso | 7 | 0.35 | 6.3e-47 | -5.1 | 5.2 | 2.4e-07 | -0.97 | 0.02 | 0.98 | FALSE |
12 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | RHCE | 0.10 | 0.03 | blup | 18 | 0.03 | 1.1e-03 | -5.1 | 5.1 | 3.0e-07 | -0.97 | 0.01 | 0.94 | FALSE |
13 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | TMEM50A | 0.07 | 0.02 | blup | 7 | 0.02 | 1.3e-02 | -5.2 | 5.2 | 1.6e-07 | -0.96 | 0.00 | 0.54 | FALSE |
14 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LDLRAP1 | 0.03 | 0.01 | blup | 21 | 0.01 | 9.5e-03 | -5.1 | 5.3 | 8.6e-08 | -0.79 | 0.00 | 0.70 | FALSE |
15 | The Cancer Genome Atlas | Breast Invasive Carcinoma | RHCE | 0.13 | 0.08 | lasso | 3 | 0.08 | 1.3e-16 | -5.2 | 5.2 | 1.6e-07 | -0.99 | 0.01 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Breast Invasive Carcinoma | TMEM57 | 0.06 | 0.02 | lasso | 3 | 0.02 | 2.3e-05 | -5.2 | 5.2 | 2.0e-07 | -0.97 | 0.01 | 0.98 | FALSE |
17 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | TMEM50A | 0.10 | 0.04 | enet | 3 | 0.04 | 6.1e-03 | -5.2 | 5.2 | 1.6e-07 | -1.00 | 0.00 | 0.76 | FALSE |
18 | The Cancer Genome Atlas | Colon Adenocarcinoma | RHCE | 0.20 | 0.13 | enet | 8 | 0.10 | 3.7e-06 | -5.2 | 5.3 | 1.4e-07 | -0.99 | 0.01 | 0.98 | FALSE |
19 | The Cancer Genome Atlas | Colon Adenocarcinoma | TMEM57 | 0.06 | 0.03 | enet | 6 | 0.02 | 1.5e-02 | -5.1 | 5.2 | 1.5e-07 | -0.95 | 0.01 | 0.56 | FALSE |
20 | The Cancer Genome Atlas | Glioblastoma Multiforme | RHCE | 0.13 | 0.02 | blup | 18 | 0.04 | 3.0e-02 | -5.2 | 5.4 | 8.5e-08 | -0.97 | 0.01 | 0.38 | FALSE |
21 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | RHCE | 0.15 | 0.03 | blup | 18 | 0.03 | 1.3e-04 | -5.1 | 5.1 | 3.1e-07 | -0.98 | 0.01 | 0.96 | FALSE |
22 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | RHD | 0.07 | 0.01 | blup | 7 | 0.01 | 6.6e-02 | -5.2 | -5.2 | 2.2e-07 | 0.93 | 0.00 | 0.38 | FALSE |
23 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | TMEM50A | 0.08 | 0.02 | blup | 7 | 0.02 | 1.5e-03 | -5.2 | 5.4 | 7.5e-08 | -0.96 | 0.00 | 0.66 | FALSE |
24 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | RHCE | 0.06 | 0.05 | blup | 18 | 0.05 | 1.4e-06 | -5.1 | 5.2 | 2.6e-07 | -0.98 | 0.01 | 0.98 | FALSE |
25 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | TMEM50A | 0.02 | 0.02 | lasso | 1 | 0.02 | 5.2e-03 | -5.2 | 5.2 | 1.9e-07 | -0.99 | 0.00 | 0.54 | FALSE |
26 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | RHCE | 0.09 | 0.05 | enet | 3 | 0.04 | 2.4e-03 | -5.2 | 5.3 | 1.2e-07 | -0.97 | 0.01 | 0.86 | FALSE |
27 | The Cancer Genome Atlas | Brain Lower Grade Glioma | RHCE | 0.38 | 0.20 | lasso | 3 | 0.22 | 4.9e-24 | -5.2 | 5.3 | 1.2e-07 | -0.96 | 0.01 | 0.99 | FALSE |
28 | The Cancer Genome Atlas | Brain Lower Grade Glioma | TMEM57 | 0.07 | 0.04 | lasso | 3 | 0.05 | 9.1e-07 | -4.9 | 5.2 | 2.1e-07 | -0.90 | 0.02 | 0.97 | FALSE |
29 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | RHCE | 0.21 | 0.15 | blup | 18 | 0.18 | 6.3e-09 | -5.1 | 5.1 | 3.0e-07 | -0.92 | 0.02 | 0.98 | FALSE |
30 | The Cancer Genome Atlas | Lung Adenocarcinoma | RHCE | 0.16 | 0.07 | blup | 18 | 0.07 | 8.0e-09 | -5.1 | 5.2 | 2.0e-07 | -0.98 | 0.01 | 0.98 | FALSE |
31 | The Cancer Genome Atlas | Lung Adenocarcinoma | TMEM50A | 0.11 | 0.03 | lasso | 2 | 0.03 | 1.9e-04 | -5.1 | 5.2 | 2.2e-07 | -0.97 | 0.00 | 0.92 | FALSE |
32 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | RHCE | 0.09 | 0.06 | blup | 18 | 0.06 | 1.3e-07 | -5.1 | 5.2 | 2.2e-07 | -0.97 | 0.02 | 0.98 | FALSE |
33 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | TMEM57 | 0.02 | 0.00 | blup | 20 | 0.00 | 2.0e-01 | -4.9 | 5.2 | 2.1e-07 | -0.96 | 0.01 | 0.43 | FALSE |
34 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | RHCE | 0.18 | 0.14 | lasso | 2 | 0.15 | 3.6e-10 | -5.2 | 5.2 | 1.7e-07 | -0.99 | 0.01 | 0.99 | FALSE |
35 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | TMEM57 | 0.04 | 0.02 | blup | 20 | 0.01 | 3.9e-02 | -5.1 | 5.2 | 2.2e-07 | -0.96 | 0.01 | 0.64 | FALSE |
36 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | RHCE | 0.12 | 0.08 | lasso | 3 | 0.07 | 7.8e-04 | -5.2 | 5.2 | 1.7e-07 | -1.00 | 0.01 | 0.81 | FALSE |
37 | The Cancer Genome Atlas | Rectum Adenocarcinoma | RHCE | 0.23 | 0.04 | blup | 17 | 0.04 | 4.4e-02 | -5.2 | 5.2 | 1.7e-07 | -0.98 | 0.00 | 0.22 | FALSE |
38 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | RHCE | 0.29 | 0.03 | blup | 17 | 0.01 | 2.0e-01 | -5.2 | 5.3 | 1.4e-07 | -0.97 | 0.01 | 0.51 | FALSE |
39 | The Cancer Genome Atlas | Stomach Adenocarcinoma | RHCE | 0.06 | 0.05 | blup | 18 | 0.03 | 2.4e-03 | -5.2 | 5.3 | 9.3e-08 | -0.97 | 0.01 | 0.95 | FALSE |
40 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | RHCE | 0.41 | 0.23 | enet | 8 | 0.22 | 3.1e-08 | -5.1 | 5.2 | 1.8e-07 | -0.98 | 0.01 | 0.98 | FALSE |
41 | The Cancer Genome Atlas | Thyroid Carcinoma | RHCE | 0.22 | 0.11 | enet | 6 | 0.12 | 5.1e-12 | -5.1 | 5.3 | 1.1e-07 | -0.97 | 0.02 | 0.98 | FALSE |